Canaccord Genuity Group Issues Positive Forecast for Anpario (LON:ANP) Stock Price

Anpario (LON:ANPFree Report) had its target price raised by Canaccord Genuity Group from GBX 550 to GBX 570 in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock.

Separately, Shore Capital reissued a “house stock” rating on shares of Anpario in a report on Monday. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of GBX 570.

Get Our Latest Report on Anpario

Anpario Price Performance

LON ANP opened at GBX 534.07 on Thursday. Anpario has a one year low of GBX 286 and a one year high of GBX 547. The stock has a 50-day moving average of GBX 488.34 and a 200 day moving average of GBX 461.15. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The company has a market capitalization of £90.50 million, a price-to-earnings ratio of 17.97 and a beta of 0.58.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Stories

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.